In 2026, the American Cancer Society estimates 6,340 Minnesota men will be diagnosed with prostate cancer and 600 will die from the disease, making it one of the leading causes of cancer-related deaths in the state. Early detection is critical - especially for those at higher risk. Yet many men may skip screenings due to out-of-pocket costs, even when those costs are relatively low. 

In Minnesota, SF 5217, is being discussed as a way to expand access to prostate cancer screening and follow-up care by reducing or eliminating these financial barriers. Raising awareness about risk, early detection, and affordability can help improve outcomes across the state. 

Thank you for your continued commitment to supporting the health and well-being of those in Minnesota. Please use this campaign to ask your state lawmakers to pass this bill.